# MAtrix Therapy for Hard-to-heal ChrOnic Wounds

Study · id `cardio:ct-nct05170984` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05170984](<https://clinicaltrials.gov/study/NCT05170984>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05170984

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 191 participants.

## Technical summary

Registry record NCT05170984. Allocation not applicable; no masking; primary purpose treatment. Start 2022-02-10 (actual); primary completion 2024-07-01 (actual). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 191 participants (enrolled count; ClinicalTrials.gov record NCT05170984, source copy `cardio:ctgov-nct05170984-2026-04-13`, retrieved 2026-10-26)
- Started: 2022-02-10 (actual) (ClinicalTrials.gov record NCT05170984, source copy `cardio:ctgov-nct05170984-2026-04-13`, retrieved 2026-10-26)
- Primary completion: 2024-07-01 (actual) (ClinicalTrials.gov record NCT05170984, source copy `cardio:ctgov-nct05170984-2026-04-13`, retrieved 2026-10-26)
- Completion: 2024-12-30 (actual) (ClinicalTrials.gov record NCT05170984, source copy `cardio:ctgov-nct05170984-2026-04-13`, retrieved 2026-10-26)
- Countries: France (ClinicalTrials.gov record NCT05170984, source copy `cardio:ctgov-nct05170984-2026-04-13`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05170984-2026-04-13`, retrieved 2026-10-26)

## The registry's words

- Brief title: MAtrix Therapy for Hard-to-heal ChrOnic Wounds
- Acronym: MATHCOW
- Condition: Chronic Ulcer of Leg or Foot
- Condition: Diabetic Foot Ulcer
- Condition: Arterial Ulcer
- Condition: Venous Ulcer of Leg
- Intervention (Device): CACIPLIQ20®
- Lead sponsor: Organ, Tissue, Regeneration, Repair and Replacement
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Diabetes mellitus (`core:diabetes-mellitus`)

## Provenance

Content hash: 52ebfb279f869d97d2a4e97934a82b0b2eba21a35dce8b36edef9b1a274d182a
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
